Literature DB >> 19143162

Prevalence of psychoactive substance use among commercial motorcyclists and its health and social consequences in Zaria, Nigeria.

M Alti-Muazu1, A A Aliyu.   

Abstract

BACKGROUND: In recent years commercial motorcyclists (Okada riders) have come to bridge the huge public transport gap in most cities across the country. However, this is not without the dangers they pose to themselves, passengers and to other road users. It is claimed that some of these Okada riders operate under the influence of drugs and other substances. But there are few community-based studies that have investigated the problem in this part of Nigeria. Therefore, this study was conducted to determine the prevalence, health and social consequences of psychoactive substance use among commercial motorcyclists (Okada) in Zaria, northern Nigeria.
METHOD: Multi-stage sampling technique was used to sample commercial motorcyclists registered with commercial motorcyclists union in Zaria city, Kaduna state, Nigeria. Structured, closed ended and interviewer administered questionnaires were used to collect information on socio-demographic characteristics, factors influencing psychoactive substance use, impact on health status, motor cycle riding experience and work performance.
RESULTS: Two hundred commercial motor cyclists were intervi ewed, majority of them were in the age group 21-25 years (55.5%) with a mean age of 25.4 +/- 3.9 years. All the motorcyclists were male, (60.5%), had no formal education, (79.5%) are of Hausa extraction and (69%) worked for more than 10 hours per day. A high prevalence of 59.5% of road traffic accident that was associated with the use of psychoactive drugs was found among the motorcyclists. Commonly identified psychoactive substance/drugs used were: marijuana [Indian hemp] 25.8%, solution 24.5%, caffeine (Kola) 15.8%, and coffee 4.8%. Keeping awake, suppression of fatigue, and peer group effect were the identified factors influencing psychoactive substance use. The commonest types of injuries sustained were bruises and lacerations (62.5%) and fractures of upper and lower limbs (10.5%).
CONCLUSION: Road traffic accidents among commercial motorcyclists are a frequent occurrence in this part of the country. There is need for public awareness campaigns on road safety education and health consequences of psychoactive substance use among commercial motorcyclists. It is further recommended that law enforcement agencies (NAFDAC, NDLEA and FRSC) need to work in tandem so as to curb the problem of substance abuse in our society and reduce the rate of accidents on Nigerian roads.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19143162     DOI: 10.4103/1596-3519.55678

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  5 in total

1.  Health seeking behaviour and challenges in utilising health facilities in Wakiso district, Uganda.

Authors:  David Musoke; Petra Boynton; Ceri Butler; Miph Boses Musoke
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Should Traffic Offenders Undergo Compulsory "Mental Test": A Study of Mental Health and Crash Involvement Among Commercial Motorcyclists in Ibadan, Nigeria?

Authors:  Olatunde O Ayinde; Olurotimi A Adejumo; O Olukolade; Victor O Lasebikan
Journal:  Community Ment Health J       Date:  2018-08-02

3.  Psychoactive substance use and its predictors among commercial tricycle operators in Jos north local government area of Plateau State.

Authors:  Tolulope O Afolaranmi; Z I Hassan; O J Ugwu; M A Onche; J C Obasi; O G Stephen; K G Ugwu; P W Bupwatda
Journal:  J Med Trop       Date:  2020-05-20

Review 4.  Urbanization, cities, and health: The challenges to Nigeria - A review.

Authors:  Alhaji A Aliyu; Lawal Amadu
Journal:  Ann Afr Med       Date:  2017 Oct-Dec

5.  The Complex Interrelationship of Work-Related Factors Underlying Risky Driving Behavior of Food Delivery Riders in Athens, Greece.

Authors:  Vassilis Papakostopoulos; Dimitris Nathanael
Journal:  Saf Health Work       Date:  2020-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.